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Abstract
Background: Heterogeneous and uncontrolled differentiation of human embryonic stem cells (hESCs) in embryoid bodies
(EBs) limits the potential use of hESCs for cell-based therapies. More efficient strategies are needed for the commitment and
differentiation of hESCs to produce a homogeneous population of specific cell types for tissue regeneration applications.
Methodology/Principal Findings: We report here that significant chondrocytic commitment of feeder-free cultured human
embryonic stem cells (FF-hESCs), as determined by gene expression and immunostaining analysis, was induced by co-
culture with primary chondrocytes. Furthermore, a dynamic expression profile of chondrocyte-specific genes was observed
during monolayer expansion of the chondrogenically-committed cells. Chondrogenically-committed cells synergistically
responded to transforming growth factor-b1 (TGF-b1) and b1-integrin activating antibody by increasing tissue mass in
pellet culture. In addition, when encapsulated in hydrogels, these cells formed cartilage tissue both in vitro and in vivo.I n
contrast, the absence of chondrocyte co-culture did not result in an expandable cell population from FF-hESCs.
Conclusions/Significance: The direct chondrocytic commitment of FF-hESCs can be induced by morphogenetic factors
from chondrocytes without EB formation and homogenous cartilage tissue can be formed in vitro and in vivo.
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Introduction
Articular cartilage is an avascular tissue that provides structural
support and weight bearing function in diarthrodial joints.
Functional loss of articular cartilage due to trauma or chronic
disease may lead to debilitating conditions and osteoarthritis [1].
Tissue engineering is a multidisciplinary field of research that aims
to regenerate damaged tissues and restore organ function through
use of biomaterials and/or cells. Current therapies for cartilage
repair are generally surgical including stimulation of bone marrow
or autologous chondrocyte transplantation (ACT) with or without
additional biomaterials [2,3]. However, these strategies for repair
often result in inferior cartilage tissue production, due in part to
the limited proliferation and differentiation capability of the repair
cells [4]. Therefore, there is a significant need to develop
alternative cell sources that are easily cultured and are capable
of yielding large cell numbers while retaining the capacity to
differentiate and form cartilage tissue.
Bone marrow-derived mesenchymal stem cells (MSCs) have
been investigated as candidate cells for musculoskeletal tissue
regeneration applications including cartilage and bone [5–9].
MSCs have reached clinical testing, with potential repair
mechanisms identified as direct tissue formation and/or secretion
of trophic factors [10]. Even though MSCs are capable of multi-
lineage differentiation, they can proliferate only to a limited degree
and recent studies have suggested that cartilage engineered from
MSCs may not be robust and stable in prolonged in vivo
transplantation [11–14]. Human embryonic stem cells (hESCs),
on the other hand, can proliferate significantly while still retaining
the ability to differentiate into all three germ lineages [15]. Upon
withdrawal of self-renewal factors, hESCs spontaneously differen-
tiate towards numerous lineages [16]. A heterogeneous population
of differentiated cells from hESCs may lead to inferior tissue
function and organization of engineered tissues [16,17]. There-
fore, the potential use of hESCs for tissue engineering applications
relies on the development of strategies to control and efficiently
produce a homogenous cell population [18].
Chondrogenic differentiation of ESCs has previously been
achieved by supplementation of growth factors such as bone
morphogenetic protein-2, -4 or transforming growth factor-b1
[19–21]. We recently demonstrated that chondrocyte-secreted
morphogenetic factors can promote the differentiation of mesen-
chymal cells and provide survival signals, resulting in enhanced
expression of chondrocytic genes and ultimately cartilaginous
nodule formation [22]. In the present study, we investigated hESC
differentiation into a chondrocytic phenotype, without the
formation of EBs, by co-culture with chondrocytes in the
Transwell culture system. Our results indicate that Transwell co-
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and retained a chondrocyte phenotype during monolayer
expansion. Moreover, when the chondrogenically-committed cells
were encapsulated in poly(ethylene-glycol)-based hydrogels, they
formed homogenous cartilage-like tissue in vitro and in vivo, without
evidence of teratoma formation.
Materials and Methods
Feeder free culture of human embryonic stem cells
The BG02 hES cell line was obtained from Bresagen (Athens,
GA) and cultured according to manufacturer’s instructions. For
feeder-free culture, hES cell cultures were dissociated into small
clumps by incubating at 37uC for 30 minutes with 1 mg/ml
collagenase IV (GIBCO, Gaithersburg, MD) and subsequently
plated onto laminin-coated tissue culture plates and maintained
with mouse embryonic fibroblast (MEF)-conditioned medium, as
previously described [23,24].
Chondrocyte isolation and co-culture
For chondrocyte isolation, full thickness bovine cartilage
(Research 87, Massachusetts) was harvested and cartilage pieces
were digested in Dulbeco’s Modified Eagle’s Medium (DMEM,
GIBCO, Grand Island, NY, U.S.A.) containing 0.2% collagenase
(Worthington Biochemical Corporation, Lakewood, NJ, U.S.A.)
and 5% fetal bovine serum (Hyclone) for 16 hours at 37uC, as
previously described [25]. The cell suspension was then filtered
through a 70 mm nylon filter (Cell Strainer; Falcon, Franklin
Lakes, NJ, U.S.A.) and washed three times with Phosphate
Buffered Saline (PBS) containing 100 U/ml penicillin and 100 mg/
ml streptomycin. Isolated chondrocytes were seeded onto
Transwell
TM inserts (6 well plates) with a porous membrane
(0.4 mm pore size) and lowered into the FF-hESCs wells for co-
culture. Prior to co-culture, FF-hESCs were maintained in MEF-
conditioned medium as colonies. Cells were co-cultured for 21
days in DMEM supplemented with 10% FBS, and 5000 U/mL
penicillin and 5000 U/mL streptomycin, and 1 mM L-glutamine.
Control FF-hESCs were maintained with DMEM supplemented
with 10% FBS, and 5000 U/mL penicillin and 5000 U/mL
streptomycin, and 1 mM L-glutamine. Medium was aspirated and
exchanged twice a week. For co-culture experiments, chondrocytes
were replenished at day 7 and day 14 with freshly isolated cells.
After 3 weeks of co-culture, Transwell inserts with chondrocytes
were removed. Chondrocyte-stimulated FF-hESCs were then
trypsinized (0.25% trypsin/EDTA) and sequentially expanded at
a seeding density of 2610
4 per cm
2 in DMEM supplemented with
10% FBS, and 5000 U/mL penicillin and 5000 U/mL
streptomycin, and 1 mM L-glutamine.
Photoencapsulation
Chondrogenically-committed cells from hESCs (P8) were encap-
sulated into poly(ethylene glycol)-diacrylate (PEGDA) or tyrosine-
arginine-glycine-aspartate-serine (YRGDS)-modifiedPEGDAhydro-
gels (PEG-RGD), as previously described [26]. Briefly, the PEGDA
hydrogel solution was prepared by mixing 10% (w/v) PEGDA
(SunBio Inc., Korea) in sterile phosphate-buffered saline (PBS) with
penicillin (100 U/ml) and streptomycin (100 mg/ml, GIBCO). For
PEG-RGD hydrogels, YRGDS was reacted with acryloyl-PEG-N-
hydroxysuccinimide (acryloyl-PEG-NHS, 3400 MW; Nektar) in
50 mM TRIS buffer (pH 8.2) for 2 hours at room temperature. The
product was lyophilized and the final concentration of the polymer
solution (10% w/v) containing 2.5 mM RGD was prepared by
mixing PEGDA and YRGDS-PEG-Acrylate in sterile PBS. Cells
were gently mixed with the polymer solution at a concentration of
2610
7 cells/ml and photopolymerized with photoinitiator (Irgacure
2959, 0.05% w/v) using 365-nm light (4.5 mW/cm
2) for 5 minutes.
The constructs (total volume of 100 ml) were then cultured at 37uC
with 5% CO2 in 2.5 ml chondrogenic differentiating medium for 3
weeks.
Pellet culture
For pellet cultures, 2.5610
5 cells (P7) were collected in 1 ml
Eppendorf tubes and centrifuged at 6150g for 5 minutes. Serum-
free chondrogenic medium was prepared with DMEM (GIBCO)
containing 2 mM L-glutamine, 100 nM dexamethasone, 50 mg/
ml ascorbic acid phosphate (Wako, Neuss, Germany), 1 mM
sodium pyruvate, 40 mg/ml proline, 1% ITS+ (Collaborative
Biomedical Products, Bedford, MA) in the presence or absence of
10 ng/ml transforming growth factor (TGF)-b1. The effects of
integrin activation were determined by incubation of pellets (n=6)
with blocking antibodies anti-b1 (Chemicon, Temecula, CA) or
activator anti-b1 antibody (Chemicon).
Cell proliferation
Growth kinetics of cells were monitored by plating at densities
ranging 2500 cells/cm
2 to 2610
4 cells/cm
2 in 6-well tissue culture
plates. Cells were serially passaged using trypsin/EDTA (Invitro-
gen) and counted using a Z2 Coulter Particle Counter.
Reverse transcriptase-PCR and real-time PCR
Total RNA was extracted with Trizol. Two micrograms of total
RNA per 20 ml of reaction volume were reverse-transcribed into
cDNA using SuperScript First-Strand Synthesis System (Invitro-
gen). Real Time-PCR reactions were performed using the SYBR
Green PCR Mastermix and the ABI Prism 7700 Sequence
Detection System (Perkin Elmer/Applied Biosystems, Rotkreuz,
Switzerland). cDNA samples (2 ml for total volume of 25 ml per
reaction) were analyzed for gene of interest and for the reference
gene b-actin. The level of expression of each target gene was then
calculated as –2
DDCt as previously described [27]. Each sample
was repeated at least three times for the gene of interest. The PCR
primers are listed in Table 1.
Subcutaneous transplantation into athymic nude mouse
Animals were anesthetized via intraperitoneal injection of
7.5 mg/kg ketamine, 0.24 mg/kg acepromazine and 1.5 mg/kg
xylazine. Chondrogenically-committed cells (P8) encapsulated in
PEGDA and PEG-RGD hydrogels (n=6) were implanted
subcutaneously into the dorsal region of 6 to 8-week-old athymic
mice for 12 and 14 weeks. Harvested constructs were processed for
biochemical analysis. In addition, constructs were fixed in 4%
paraformaldehyde for 24 hours at 4uC and further processed for
histology and immunohistochemistry.
Biochemical assays
Biochemical assays were performed on hydrogel constructs
harvested from animals after 12 and 24 weeks. Constructs (n=6)
were digested in papainase solution (construct/1 ml papainase
solution; 125 mg/mL, Worthington Biomedical, Lakewood, NJ)
for 16 hours at 60uC. The DNA content was determined by
Hoescht 33258 dye assay, as previously described [7]. The GAG
content was quantified using dimethylmethylene blue (DMMB)
spectrophotometric assay at A525, as previously described [28].
Total collagen content was determined by measuring the
hydroxyproline content of the constructs after acid hydrolysis
and reaction with p-dimethylaminobenzaldehyde and chloramine-
T, as previously described [29].
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For immunostaining, cells were fixed in 4% paraformaldehyde,
rinsed with PBS and permeated with 0.1% Triton in PBS. Cells
were blocked with 5% normal goat serum in PBS for 30 minutes,
and incubated with rabbit polyclonal antibodies against Types I
and II collagen (RDI, Flanders, NJ), Oct-4, SSEA-4, and Tra-180
(Chemicon) with 1:100 dilutions. Cells were incubated with either
FITC- or Texas Red- conjugated goat anti-rabbit secondary
antibody (all 1:100 dilutions) for 1 hour (Jackson ImmunoR-
esearch laboratory, West Grove, PA). Nuclei were counterstained
with DAPI (Chemicon) for 10 minutes. Images were collected
with a Zeiss LSM Metal Confocal microscope. For histological
analysis, constructs were fixed in 4% paraformaldehyde, dehy-
drated in serial ethanol dilutions, and paraffin embedded.
Constructs were then cut into 5 mm sections and stained with
Safranin-O/fast green or hematoxylin and eosin. Immunohisto-
chemistry for Types I, II, and X collagen were performed as
previously described [19].
Statistical analysis
Data are expressed as mean6standard deviation (SD). Statis-
tical significance was determined by analysis of variance (ANOVA
single factor) with *P,0.05 or **P,0.01.
Results
Feeder free culture of human embryonic stem cells
The BG02 human embryonic stem cell (hESC) line was
maintained feeder free by culturing on laminin-coated culture
dishes with mouse embryonic fibroblast (MEF)-conditioned hESC
medium, supplemented with 4 ng/ml bFGF [23]. Feeder free-
conditioned hESCs (FF-hESCs) proliferated in colonies, and were
capable of forming embryoid bodies (EBs) (data not shown). FF-
hESCs retained the expression of the pluripotent marker Oct-4, a
POU domain transcription factor exclusively expressed in
undifferentiated hESCs (Figure 1A). In addition, SSEA-4 and
TRA-180 were also detected via immunostaining (Figure 1A).
Generation of chondrogenically-committed cells
Recent studies suggest that morphogenetic factors from
chondrocytes can induce chondrogenic differentiation of mesen-
chymal progenitor cells and hESCs [22,30]. To investigate
whether chondrocyte-secreted morphogenetic factors can stimu-
late the chondrogenic commitment of hESCs without EB
formation, FF-hESCs were co-cultured with primary chondrocytes
for 3 weeks using a Transwell tissue culture system (Figure 1B).
After 3 weeks of co-culture, FF-hESCs were further expanded in
monolayer culture. Upon initial replating, the adherent cell
population displayed fibroblastic morphology. Immunostaining
indicated that the chondrocyte-stimulated cells expressed both
Type I collagen and Type II collagen (Figure 1C). RT-PCR
analysis indicated that chondrocyte co-cultured FF-hESCs upre-
gulated Type II collagen and aggrecan gene expression while
inhibiting the expression of hematopoietic and myogenic genes
such as FLK1 and Myf5. In addition, chondrocyte co-cultured FF-
hESCs upregulated the expression of TGF-b1-RII with no
significant upregulation of the osteogenic markers ALP and
BMP4-RII genes, suggesting that co-culture resulted in chondro-
cytic differentiation of FF-hESCs (Figure 1D). In contrast, control
FF-hESCs that were maintained in DMEM (10% FBS) for 3 weeks
without the chondrocyte co-culture expressed multiple lineage
markers, indicating heterogeneous differentiation of the hESCs.
Characterization of chondrogenic-committed cells from
hESCs
We further characterized the chondrogenic-committed cells
from FF-hESCs in monolayer. Upon initial plating of the
chondrogenically-committed cells, 100% of the cells stained
positive for Type I collagen and approximately 85% of the cells
were Type II collagen positive (Figure 2A, B, and C). Proliferation
was assessed by initially plating the cells at a density of 2610
4
cells/cm
2 and monitoring cell number at confluence. Chondrocyte
co-culture resulted in an expandable cell population from FF-
hESCs with increased telomerase activity compared to that of
control FF-hESCs (Figure 2E). Chondrogenically-committed cells
initially displayed a low proliferation rate, however proliferation
increased significantly after subsequent passaging (Figure 2D). The
gene expression profile of chondrogenically-committed cells
showed a dynamic expression of chondrocyte-specific markers
(Figure 3A). Upon co-culture, chondrogenically-committed cells
expressed high levels of Type II collagen; however, these cells
rapidly lost Type II collagen gene expression upon expansion. At
P3, these cells produced no detectable expression of Type II
Table 1. Primer Sequences
Gene Primer Sequences (59-39) Predicted size (bp)
AGN F-tgaggagggctggaacaagtacc 350
R-ggaggtggtaattgcagggaaca
Col I F-tgacgagaccaagaactg 600
R-ccatccaaaccactgaaacc
Col II F-tttcccaggtcaagatggtc 377
R-cttcagcacctgtctcacca
Nestin F-gccctgaccactccagttta 200
R-ggagtcctggatttccttcc
flk-1 F-ggtattggcagttggaggaa 199
R-acatttgccgcttggataac
myf5 F-tcacctcctcagagcaacct 193
R-tgaagccttcttcgtcctgt
ALP F-acgtggctaagaatgtcatc 476
R-acatttgccgcttggataac
Col X F-ccctttttgctgctagtatcc 468
R-ctgttgtccaggttttcctggcac
COMP F-caggacgactttgatgcaga 314
R-aagctggagctgtcctggta
link protein F-gctctgtgcaatatcccatc 232
R-cccacttttgcaatgtgagc
Sox-9 F-acgtcatctccaacatcgagacc 4454
R-ctgtagtgtgggaggttgaaggg
Cbfa1 F-ccacccggccgaactggtcc 258
R-cctcgtccgctccggcccaca
BMP4-RII F-tagtcactgacaacaacggtgcagtc 816
R-tatactgctccatatcgacctcggc
TGF-B-RII F-tagtcactgacaacaacggtgcagtc 539
R-acagtgctcgctgaactccatgagc
TERT F-agctatgcccggacctccat 185
R-gcctgcagcaggaggatctt
b-actin F-tggcaccacaccttctacaatgagc 396
R-gcacagcttctccttaatgtcacgc
doi:10.1371/journal.pone.0002498.t001
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regained Type II collagen gene expression, and reduced Type I
collagen gene expression, upon further expansion (Figure 3A).
Aggrecan and link protein were highly expressed at early passages
and retained their expression throughout culture. Type X
collagen, a hypertrophic chondrocyte marker, was not found in
any of the cultures either by RT-PCR or immunostaining.
Immunostaining for Types I and II collagen confirmed the real
time-PCR results (Figure 3B). At P3, Type II collagen was not
detected, however Type II collagen positive cells were found at P7
(Figure 3B).
Effects of TGF-b1 and b1-integrin on cartilaginous tissue
development
The pellet culture system is a standard method to screen three
dimensional cartilage forming capacity [21,31]. To examine the
cartilage tissue forming abilities of chondrogenic-committed cells,
pellets were formed and cultured for 3 weeks in chondrogenic
medium in the presence or absence TGF-b1 (10 ng/ml). Initial gross
observation of the pellets after 3 weeks indicated that TGF-b1
stimulated matrix production and cartilage-like tissue formation
(Figure 4A). Supplementation with TGF-b1 in the medium resulted
in a 245% increase in pellet weight (Figure 4C). However,
chondrogenic-committed cells in pellets, regardless of TGF-b1
supplementation, displayed a spherical morphology typical of
chondrocytes and were surrounded by an abundant extracellular
matrix with glycosaminoglycans and Type II collagen, as detected by
Safranin-O staining and immunohistochemistry for Type II collagen,
respectively (Figure 4A, B). In contrast, Type I collagen and Type X
collagen were detected with less intensity (Figure 4A, B).
We further investigated whether activation of b1-integrin plays
a role in chondrogenic differentiation and cartilage tissue
formation (Figure 4C). b1-integrin activating antibody or blocking
antibodies were supplemented in the medium and pellets were
cultured for 3 weeks. In the presence of TGF-b1, activation of b1-
integrin resulted in increased pellet weight; while in the absence of
TGF-b1, activation of b1-integrin resulted in slightly lower weight
compared to control pellets. Inhibition of b1-integrin activity with
blocking antibody in the presence of TGF-b1 also resulted in
reduced pellet weight. In the absence of TGF-b1, blocking b1-
integrin did not stimulate pellet weight. Activation of b1-integrin
in the presence of TGF-b1 synergistically enhanced matrix
production; however b1-integrin stimulation in the absence of
TGF-b1 may be compromised.
In vitro cartilage development in hydrogels
The pellet is a useful screening system to evaluate the
chondrogenic potential of cells; however it does not yield the
large tissue volumes that are needed in clinical settings of cartilage
loss. Our laboratory and others have developed a PEG-based
photopolymerizing hydrogel that can be implanted in clinically-
relevant articular cartilage defects. The hydrogel system also
supports simple polymer modification with integrin binding
peptides such as tyrosine-arginine-glycine-aspartate-serine
(YRGDS) [32–35]. These hydrogels are hydrophilic, biocompat-
ible scaffolds that allow diffusion of nutrients and signaling
molecules to support formation of large tissue volumes (Figure 5A).
We therefore investigated the in vitro cartilaginous tissue forming
abilities of chondrogenic-committed cells (P8) encapsulated in
PEGDA or YRGDS-modified PEG-based hydrogels (PEG-RGD)
Figure 1. Derivation of chondrogenically-committed cells from FF-hESCs. (A) FF-BG02 hESCs maintained with MEF-conditioned medium
supplemented with 4 ng/ml bFGF (bar=100 mm) expressed Oct-4, SSEA-4, and Tra-180. (B) FF-hESCs were then co-cultured with chondrocytes in
Transwell tissue culture for 3 weeks. (C) Upon stimulation, fibroblastic cells appeared (as indicated by actin phalloidin staining, red) and stained
positive for both Type I collagen and Type II collagen (bar=20 mm). (D) RT-PCR confirmed that chondrocyte co-culture resulted in upregulation of
cartilage-specific markers including aggrecan, Type II collagen, and TGF-b-RII gene expressions and decreased expression of FLK1 and Myf5.
doi:10.1371/journal.pone.0002498.g001
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mediumcontainingTGF-b1for3weeks.PEG-RGDhydrogelswere
utilized to provide adhesion sites for b1-integrins for stimulation
similar to the pellet cultures. Histological analysis of both hydrogels
indicated the formation of cartilage-like tissues as indicated by the
presence of basophilic ECM components (Figure 5B). Cells in the
PEG-RGD hydrogels produced greater Safranin-O staining,
indicating more proteoglycan secretion. In addition, PEG-RGD
hydrogels stimulated the expression of cartilage specific genes
compared to the cells in the PEGDA hydrogels (Figure 5C).
Throughout the in vitro culture, aggrecan, Type II collagen, Sox-9,
and Cbfa1 genes were highly expressed in PEG-RGD hydrogels in
contrastto cells inthe PEGDA hydrogels. Geneexpression of cells in
the PEG-RGD hydrogels mimicked aspects of the early mesenchy-
mal condensation process, and chondrogenically-committed cells
with Sox-9 expression peaking at day 7, followed by upregulation of
Type II collagen and Comp genes.
Chondrogenic-committed cells from hESCs maintain
chondrocyte phenotype in long-term in vivo
transplantation
To validate the capacity of chondrogenically-committed cells to
maintain chondrocyte phenotype in vivo, expanded cells (P8) were
transplanted into athymic nude mice in PEGDA or PEG-RGD
hydrogels, without exogenous growth factors. No evidence of
teratoma formation was observed in any of the tissue constructs.
Histological examination of the cells revealed cartilage tissue
formation in both hydrogels at 12 weeks and 24 weeks (Figure 6A,
B). Cells in both hydrogels were surrounded by Safranin-O-
positive extracellular matrix. Immunohistochemistry at 12 and 24
weeks demonstrated an ECM in both hydrogels comprised
primarily of Type II collagen, with Types I and Type X collagen
also present (Figure 6A, B). Biochemical analyses indicated similar
cellularity in both hydrogels and an extracellular matrix comprised
of proteoglycans and collagens (Figure 7A, B, C). Greater amounts
of GAG and collagen were observed in PEG-RGD hydrogels
compared to PEGDA hydrogels at 12 weeks. However, after 24
weeks, more GAG accumulated in PEGDA hydrogels, with
comparable amounts of collagen detected in both hydrogels.
Discussion
The success of hESC-based cartilage tissue engineering depends
in part on the development of efficient strategies to control cell
differentiation along with tissue production and maintenance.
Conventional methods to differentiate hESCs include EB
formation. However, EBs generally contain a mixture of cells,
differentiated into multiple lineages, highlighting the challenge of
achieving a homogenous cell population [36]. To circumvent the
production of a heterogenous EBs, we utilized FF-hESCs for direct
differentiation into a chondrocytic lineage, devoid of EB
formation. Chondrocyte-secreted morphogenetic factors were
harnessed to create a more uniform microenvironment to
stimulate chondrogenic commitment without the addition of
Figure 2. Characterization of chondrogenically-committed cells. At P1 most of the cells stained positive for both Types I and II collagen. (A)
Immunostaining of Type I collagen and (B) Type II collagen at P1. (C) Quantification of cells positive for Types I and II collagen at P1 (n=4 wells). (D)
Proliferation rate of the chondrogenic-committed cells was measured by counting the cells during expansion. (E) At P1, chondrogenic-committed
cells showed enhanced expression of telomerase gene compared to that of hESCs that were not cocultured (at P1). (** P,0.01, bar=100 mm)
doi:10.1371/journal.pone.0002498.g002
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cultured in chondrogenic medium supplemented with or without TGF-b1 (10 ng/ml) for 3 weeks. (A) Safranin-O staining and Type I, Type II, and Type
X collagen immunohistochemistry of pellets cultured without TGF-b1. (B) Safranin-O staining and Type I, Type II, and Type X collagen
immunohistochemistry of pellets cultured in the presence of TGF-b1. (C) Pellets were weighed after 3 weeks of culture, with or without b1-integrin
activating antibody or blocking antibody (n=5). (* P,0.05, bar=100 mm)
doi:10.1371/journal.pone.0002498.g004
Figure 3. Expansion of chondrogenic-committed cells in vitro. (A) Dynamic expression profile of chondrocyte-specific genes observed during
the expansion. Note that coculture-stimulated Type II collagen gene expression present at P0 and subsequently lost at P3 and P4. However, these
cells slowly regained the expression of Type II collagen upon expansion (P5-8). (B) Immunostaining for Types I and II collagens confirmed real-time
PCR. Note Type X collagen was not detected at any time. (bar=20 mm)
doi:10.1371/journal.pone.0002498.g003
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from FF-hESCs were identified by Type II collagen immuno-
staining and expression of chondrocyte-specific genes. Three
weeks of chondrocyte co-culture resulted in a significant number of
FF-hESC-derived cells expressing Type II collagen. In addition,
RT-PCR analysis demonstrated that the chondrocyte co-culture
resulted in the upregulation of chondrocyte specific markers in the
FF-hESCs and decreased markers of other lineages. Critical for
engineering tissues, the co-cultured cells maintained a chondrocyte
phenotype in vitro and in vivo.
In this study, we utilized morphogenetic factors secreted from
bovine articular chondrocytes to provide the commitment signals.
The exact molecule(s) responsible for differentiation of the hESCs
still remains a question. Our initial screen of growth factors
indicated that differentiation was independent of the TGF-beta
family-mediated signaling pathway (data not shown). Recently
Kim et al., identified a novel molecule (Cytokine-like 1, Cytl1)
secreted by chondrocytes which regulated multiple steps of
mesenchymal condensation and chondrogenesis [37]. Cytl1
expression was strongly correlated with chondrocyte differentia-
tion and was mainly expressed in terminally differentiated
chondrocytes both in vivo and in vitro [37]. Exogenous Cytl1 and
overexpression of Cytl1 demonstrated the capacity of this protein
to induce chondrogenic differentiation of mesenchymal cells while
preventing hypertrophy [37]. In addition, a study by D’Angelo et
al., found that co-culture of articular chondrocytes with mesen-
chymal cells resulted in reduced hypertrophy [38]. Paracrine
factors, secreted by chondrocytes, interacted with the stem cells,
leading to direct expression of cartilage specific markers and
prevention of further differentiation into heterotypic or hypertro-
phic tissues. Elucidation of the molecular signals stimulated by
chondrocyte-secreted factors would lead to a better understanding
of chondrogenic commitment of hESCs and likely improve hyaline
cartilage tissue engineering efforts.
In the present study, cells were cocultured in DMEM containing
10% FBS. Cocultured FF-hESCs exhibited increased viability and
eventually a significant proliferative potential. This observation is
in accordance with previous reports where morphogenetic factors
from chondrocytes enhanced the survival of mesenchymal cells
and stimulated chondrogenic differentiation [22,39]. However,
culture in DMEM with 10% FBS medium in the absence of
coculture resulted in heterogeneous differentiation of FF-hESCs
after 3 weeks. In addition, FF-hESCs in DMEM with 10 % FBS
resulted in greater cell death and cell senescence after trypsiniza-
tion (0.25% Trypsin/EDTA).
To date, the chondrogenic differentiation of ESCs has required
the addition of exogenous growth factors such as TGF-b1o r
BMP-2 [19,20,40]. A recent study by Vats et al., suggested that the
chondrogenic differentiation of hESCs can be achieved by co-
culture with chondrocytes, without exogenous growth factors [30].
Similarly, we demonstrated that chondrocyte co-culture can result
in chondrogenically-committed cells, with approximately 85% of
cells staining positive for Type II collagen, without exogenous
addition of growth factors. Chondrogenic-committed cells derived
from FF-hESCs behaved similar to primary chondrocytes,
exhibiting characteristics of dedifferentiation during early expan-
sion [41]. We speculate that initial coculture resulted in
coordinated signaling between cells, resulting in morphogenetic
Figure 5. (A) Gross image of a poly(ethylene glycol)-diacrylate (PEGDA) hydrogel. (bar=5 mm) (B) Safranin-O and H&E staining of
chondrogenic-committed cells in PEGDA or PEG-RGD hydrogels after 3 weeks in vitro culture. (bar=100 mm) (C) Real-time PCR analysis indicated
distinct cellular response in RGD-modified hydrogels.
doi:10.1371/journal.pone.0002498.g005
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but rapid phenotype loss upon expansion in DMEM with 10%
FBS medium. Expansion of the chondrogenic-committed cells in
chondrocyte-conditioned medium delayed the dedifferentiation
process (Figure S1). However, upon further expansion, the
chondrogenic-committed cells regained their phenotype with
Type II collagen expression. An elucidation of pathways regulating
the phenotypic stability of chondrogenic-committed cells may
provide strategies for efficiently generating more stable cells for
cartilage repair using hESCs.
Designing biomaterials that stimulate ECM-cell interactions is
an important component of utilizing stem cells for tissue
Figure 6. Histological analysis of in vivo engineered cartilage tissue. Chondrogenic-committed cells (P8) were encapsulated in PEGDA or
PEG-RGD hydrogels and subcutaneously transplanted into athymic nude mice for (A) 12 weeks and (B) 24 weeks. Basophilic extracellular matrix
deposition was observed and cells stained positive for Types I, II, and X collagen at both time points. (bar=100 mm)
doi:10.1371/journal.pone.0002498.g006
Figure 7. Biochemical analysis of in vivo engineered cartilage tissues. Quantification of DNA and extracellular matrix production was
determined by biochemical assays. (A) DNA content was quantified with Hoechst 33258. (B) GAG content quantified by DMMB assay and normalized
to the total DNA of the construct. (C) Collagen was quantified by measuring hydroxyproline content and normalized to the total DNA of the
construct. (*P,0.05 or **P,0.01)
doi:10.1371/journal.pone.0002498.g007
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inducing ECM-cell interactions promotes cell differentiation and
tissue formation [43,44]. Specifically, recent evidence suggests b1-
integrin is a key membrane receptor for relaying ECM-mediated
signals via activating FAK and downstream signals, resulting in
enhanced matrix accumulation and tissue formation [45]. Our
study also implies that chondrogenic-committed cells responded to
b1-integrin activation, but only in the presence of TGF-b1.
Blocking b1-integrin activity resulted in reduced tissue mass. The
in vitro study with RGD-modified hydrogels confirmed that the
presence of ECM-cell interactions through integrin binding
resulted in activation of cartilage specific markers. Histologically,
cells in PEG-RGD hydrogels displayed stronger Safranin-O
staining compared to the cells in PEGDA hydrogels.
Quality of tissue formed and long-term in vivo stability are
important parameters to consider when contemplating clinical
relevance and translation. Our in vitro study showed that
chondrogenic-committed cells formed robust cartilage-like tissue
in the pellet culture system as well as porous biomaterial scaffolds
in vitro (Figure S2). In order to observe phenotypic stability of
chondrogenic-committed cells in vivo, we utilized PEG-based
hydrogels as a carrier. Long-term in vivo subcutaneous transplan-
tation of cells in PEG-based hydrogels indicated that the
chondrogenic-committed cells maintained phenotype and tissue
quality. Cells encapsulated in PEG-RGD hydrogels responded by
producing 240% more GAG and 595% more collagen at 12 weeks
compared to that of cells encapsulated in PEGDA. However, after
24 weeks of transplantation, similar amounts of collagen and
higher amounts of GAG accumulated in PEGDA hydrogels
compared to PEG-RGD hydrogels. Hyaline cartilage is composed
mainly of Type II collagen. However, chondrogenic-committed
cells in both hydrogels displayed similar levels of Types I and II
collagen, indicating some fibro-cartilaginous tissue formation in
the subcutaneous space.
The overall goal of this study was to investigate the potential of
differentiating hESCs into chondrogenically-committed cells
without the EB formation. Specifically, we designed a system to
differentiate hESCs without growth factors and produce cartilage-
like tissue that macroscopically and phenotypically resembled
native cartilage from FF-hESCs.
Supporting Information
Figure S1 Chondrogenically-committed cells dedifferentiated
upon initial expansion. At P3, chondrogenically-committed cells
mainly expressed type I collagen (A) and type II collagen (B) was
minimally detected when cultured with expansion medium
(DMEM/FBS 10%). However, expansion of the cells in
chondrocyte conditioned medium resulted in greater number of
type II collagen positive cells (C, D). (E) Quantification of type II
collagen positive cells that were expanded with either chondro-
cyte-conditioned medium (CM) or control expansion medium (C).
Found at: doi:10.1371/journal.pone.0002498.s001 (2.30 MB TIF)
Figure S2 Safranin-O staining with eosin counter staining of in
vitro cartilage tissue formation with chondrogenically-committed
cells seeded on 3-dimensional porous scaffolds. Three dimensional
porous scaffold composed of poly-(L-lactic acid) (PLLA) and poly-
(lactic-glycolic acid) (PLGA) were fabricated by initially dissolving
PLLA/PLGA 1:1 in chloroform to yield a solution of 5% (wt/vol)
polymer. 0.25 ml of polymer solution was loaded into molds
packed with 0.4 g of sodium chloride particles. The solvent was
allowed to evaporate overnight and the sponges were subsequently
immersed for 12 h in distilled water (changed every 2 hours) to
leach the salt and create pore structures. The scaffolds were soaked
in 75% (vol/vol) ethyl alcohol overnight, washed three times with
PBS, and coated with fibronectin (10 ng/ml) for 3 hours.
Chondrogenically-committed cells were seeded onto porous
scaffold and cultured for 3 weeks in chondrogenic differentiation
medium supplemented with TGF-b1 (10 ng/ml).
Found at: doi:10.1371/journal.pone.0002498.s002 (4.10 MB TIF)
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